Patents by Inventor William G. Tsiarias

William G. Tsiarias has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6649184
    Abstract: The invention provides a method for delivering biologically active molecules to the eye by implanting biocompatible capsules containing a cellular source of the biologically active molecule. Also provided is a method of treating ophthalmic diseases using biocompatible capsules.
    Type: Grant
    Filed: August 20, 2002
    Date of Patent: November 18, 2003
    Assignee: Neurotech S.A.
    Inventors: Joseph P. Hammang, E. Edward Baetge, William G. Tsiarias, Peter D. Spear
  • Publication number: 20030031700
    Abstract: The invention provides a method for delivering biologically active molecules to the eye by implanting biocompatible capsules containing a cellular source of the biologically active molecule. Also provided is a method of treating ophthalmic diseases using biocompatible capsules.
    Type: Application
    Filed: August 20, 2002
    Publication date: February 13, 2003
    Inventors: Joseph P. Hammang, E. Edward Baetge, William G. Tsiarias, Peter D. Spear
  • Patent number: 6436427
    Abstract: The invention provides a method for delivering biologically active molecules to the eye by implanting biocompatible capsules containing a cellular source of the biologically active molecule. Also provided is a method of treating ophthalmic diseases using biocompatible capsules.
    Type: Grant
    Filed: October 9, 2001
    Date of Patent: August 20, 2002
    Assignee: Neurotech S.A.
    Inventors: Joseph P. Hammang, E. Edward Baetge, William G. Tsiarias, Peter D. Spear
  • Publication number: 20020061327
    Abstract: The invention provides a method for delivering biologically active molecules to the eye by implanting biocompatible capsules containing a cellular source of the biologically active molecule. Also provided is a method of treating ophthalmic diseases using biocompatible capsules.
    Type: Application
    Filed: October 9, 2001
    Publication date: May 23, 2002
    Inventors: Joseph P. Hammang, E. Edward Baetge, William G. Tsiarias, Peter D. Spear
  • Patent number: 6299895
    Abstract: A method and device for delivering a biologically active molecule to the eye, either intraocularly or periocularly, and method and device for treating ophthalmic disorders in a patient suffering therefrom.
    Type: Grant
    Filed: April 27, 1999
    Date of Patent: October 9, 2001
    Assignee: Neurotech S.A.
    Inventors: Joseph P. Hammang, E. Edward Baetge, William G. Tsiarias, Peter D. Spear